請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84644
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林先和(Hsien-HO Lin) | |
dc.contributor.author | LI-FEI HSU | en |
dc.contributor.author | 許力霏 | zh_TW |
dc.date.accessioned | 2023-03-19T22:18:49Z | - |
dc.date.copyright | 2022-10-04 | |
dc.date.issued | 2022 | |
dc.date.submitted | 2022-09-15 | |
dc.identifier.citation | 1.WHO: Palliative Care—Key facts. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/palliative-care. [accessed 14 Jan 2022]. 2.Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. The New England journal of medicine. 2010;363(8):733-742. 3.Higginson IJ, Evans CJ. What is the evidence that palliative care teams improve outcomes for cancer patients and their families? Cancer journal (Sudbury, Mass). 2010;16(5):423-435. 4.Cihlar T, Fordyce M. Current status and prospects of HIV treatment. Current opinion in virology. 2016;18:50-56. 5.Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet (London, England). 2014;384(9939):241-248. 6.Currow DC, Agar MR, Phillips JL. Role of Hospice Care at the End of Life for People With Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020;38(9):937-943. 7.Goodkin K, Kompella S, Kendell SF. End-of-Life Care and Bereavement Issues in Human Immunodeficiency Virus-AIDS. The Nursing clinics of North America. 2018;53(1):123-135. 8.Too W, Watson M, Harding R, Seymour J. Living with AIDS in Uganda: a qualitative study of patients' and families' experiences following referral to hospice. BMC palliative care. 2015;14:67. 9.World Health Organization 2021. [Surveillance of HIV]. http://www.who.int/hiv/data/en/ [accessed 11 September 2021]. 10.Shih TC, Chang HT, Lin MH, Chen CK, Chen TJ, Hwang SJ. Trends of Do-Not-Resuscitate Orders, Hospice Care Utilization, and Late Referral to Hospice Care among Cancer Decedents in a Tertiary Hospital in Taiwan between 2008 and 2014: A Hospital-Based Observational Study. J Palliat Med. 2017;20(8):838-844. 11.Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. Journal of pain and symptom management.2007;33(3):238-246. 12.Arleen L, Diane T, Jennifer G. The Effect of Hospice on End-of-Life Costs for Terminal Medicare Patients With HIV. The Journal of Health Care Organization, Provision, and Financing. 2020;57:1-10. 13.Jacquelyn S, Maryjo PP, Allison W, Barbara D. Palliative care, hospice, and advance care planning: Views of people living with HIV and other chronic conditions. J Assoc Nurses AIDS Care. 2016;27(4): 476–484. 14.Rhodes RL, Nazir F, Lopez S, et al. Use and Predictors of End-of-Life Care Among HIV Patients in a Safety Net Health System. Journal of pain and symptom management. 2016;51(1):120-125. 15.Liu CY, Hung YT, Chuang YL, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manage. 2006;4(1):1-22. 16.Yen YF, Chung MS, Hu HY, et al. Association of pulmonary tuberculosis and ethambutol with incident depressive disorder: a nationwide, population-based cohort study. J Clin Psychiatry. 2015;76(4):e505-511. 17.Lai YJ, Chen YY, Ko MC, et al. Low Socioeconomic Status Associated With Lower Utilization of Hospice Care Services During End-of-Life Treatment in Patients With Cancer: A Population-Based Cohort Study. J Pain Symptom Manage. 2020;60(2):309-315. 18.Ta-Chou Ng, Wei-Cheng Lo, Chu-Chang Ku, Tsung-Hsueh Lu, and Hsien-Ho Lin. Improving the Use of Mortality Data in Public Health: A Comparison of Garbage Code Redistribution Models. American Journal of Public Health. 2020; 110(2):222-229 19.Kojima Y, Iwasaki N, Yanaga Y, et al. End-of-life care for HIV-infected patients with malignancies: A questionnaire-based survey. Palliative medicine. 2016;30(9):869-876. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84644 | - |
dc.description.abstract | 背景及目的 安寧照護可以改善愛滋病毒感染者在臨終期間的醫療品質、尊重病人自主權、減少非必要的住院服務、緩解病人疼痛,甚至得以延長存活時間,然而,因為愛滋病的汙名標籤,提高了為愛滋病毒感染者提供安寧照護的困難度。在臺灣,全民健保涵蓋了三種安寧照護給付,但在過去研究中,並沒有針對愛滋病毒感染個案的臨終安寧使用情形,予以廣泛性評估,因此,本研究欲探討臺灣愛滋病毒感染者與非感染者在生命末期的安寧照護使用之差異,以及在愛滋病毒感染者中,安寧照護與使用維生醫療之關聯。 研究方法 納入2000至2016年衛福部疾病管制署愛滋病資料庫中32,647名18歲以上愛滋病毒感染者,再從全民健保資料庫中配對年齡與性別,隨機選取愛滋病毒陰性者共326,470名,並利用邏輯式回歸來評估兩組的死亡個案之中,其生命末期最後一年的安寧照護使用情形,以及最後三個月的維生醫療使用,包含心肺復甦術、氣管插管、機械通氣及去顫,所有樣本皆追蹤至死亡或2018年12月31日。 研究結果 共有20,413名死亡個案,其中5,691(27.88%)為愛滋病毒感染者(對照組),14,722(72.12%)為愛滋病毒陰性者(對照組),在初步校正人口特徵及共病症之後,相較於對照組,愛滋病毒感染者在生命末期最後一年有較低的安寧照護服務使用(校正後勝算比:0.66; 95%信賴區間:0.57-0.75)。而這20,413名死亡個案中,有癌症共病者為6,225(30.50%),其中愛滋病毒感染者為1,149(18.46%),對照組為5,076(81.54%),校正後發現在這群有癌症共病的死亡個案中,愛滋病毒感染與較低的安寧照護服務使用相關(校正後勝算比:0.55; 95%信賴區間:0.47-0.64)。此外,在這5,691名愛滋病毒感染者死亡個案之中,臨終前曾使用過安寧照護為331(5.82%),不曾使用為5,360(94.18%),研究結果發現曾使用安寧照護的愛滋病毒感染者在生命末期三個月內有較低的維生醫療使用情形(校正後勝算比:0.45; 95%信賴區間:0.34-0.59)。 結論:愛滋病毒感染者在臨終治療期間有較低的安寧照護使用情況,然而,緩和醫療在於改善病人生命末期照護品質,同時尊重病人對臨終照護前治療的選擇。本篇研究結果說明為愛滋病毒感染者推動安寧照護的必要性,為愛滋病毒感染者提供安寧照護服務,可降低其臨終前三個月的維生醫療使用,進而改善臨終期間的醫療品質,以達到緩和醫療之目標。 | zh_TW |
dc.description.abstract | Background and Purpose Hospice care can improve the quality of life, respect the patient's right to choose, reduce unnecessary hospitalization services, relieve pain for patients, and even prolong survival time for people living with HIV (PLWH) during end-of-life (EOL) treatment. However, the stigma attached to AIDS makes it difficult to provide hospice care services for this group. In Taiwan, there are three types of hospice care were covered by national health insurance. Nevertheless, the impact about PLWH and hospice care has not been extensively studied. Therefore, this study aimed to investigate whether there are differences in utilization of hospice care services among PLWH and HIV-negative individuals in Taiwan, and determine the association between hospice care and life-sustaining treatments for PLWH. Methods The cohort study used data from the Taiwan Centers for Disease Control (CDC) HIV Database, identifying 32,647 adult PLWH from 2000 to 2016. And randomly selecting 326,470 subjects by age and gender from Taiwan National Health Insurance Research Database. Multiple logistic regressions were used to assess the utilization of hospice care services during the last year of life and the life-sustaining treatments during the last three months of life in deceased PLWH and deceased people without HIV/AIDS. Life-sustaining treatments included cardiopulmonary resuscitation, intubation, mechanical ventilation support, and defibrillation. All subjects were followed until death or December 31, 2018. Results There were a total of 20,413 deaths, of which 5.691 (27.88%) were PLWH (case group) and 14,722 (72.12%) were without HIV/AIDS (control group). After adjusting for demographics and comorbidities, compared with the control group, PLWH receive lower hospice care services during their last year of life (adjusted odds ratio: 0.66; 95% confidence interval: 0.57-0.75). Among 20,413 deaths, there were 6,225 (30.50%) with cancer comorbidities, of which 1,149 (18.46%) were PLWH and 5,076 (81.54%) were control group. And it was also found that PLWH with cancer comorbidities were associated with lower hospice care services (adjusted odds ratio: 0.55; 95% confidence interval: 0.47-0.64). In addition, of 5,691 deceased PLWAH, 331 (5.82%) had used hospice care during EOL Treatment, and 5,360 (94.18%) had never used hospice care. The data showed that PLWH with hospice care services were less likely to receive life-sustaining treatments during the last three months of life than those without the services (adjusted odds ratio: 0.45; 95% confidence interval: 0.34-0.59). Conclusions PLWH had a significantly lower utilization of hospice care services during the last year of life. And hospice care services reduced utilization of life-sustaining treatments during the last three months of life among PLWH. The goal of hospice care is to improve the quality of patient care at the end of life, while respecting the patient's choice of care. The results support the need to increase optimal hospice care services among PLWH during their EOL treatment. | en |
dc.description.provenance | Made available in DSpace on 2023-03-19T22:18:49Z (GMT). No. of bitstreams: 1 U0001-1509202213541000.pdf: 852149 bytes, checksum: e2660ce8507ad86bb74a6788a502c811 (MD5) Previous issue date: 2022 | en |
dc.description.tableofcontents | 目錄 論文口試委員審定書 1 致謝 2 摘要 3 Abstract 5 目錄 8 表目錄 9 第一章 導論 1.1實習單位簡介與實習情形 10 1.2研究架構與假設 10 1.3文獻回顧 11 1.4研究目的與研究問題 12 第二章 方法 2.1資料來源與研究對象 12 2.2變項定義 13 2.3統計方法 13 第三章 結果 3.1個案基本特性 13 3.2安寧照護服務使用 14 3.3維生醫療使用 14 第四章 討論與結論 4.1研究限制 15 4.2結論 15 4.3建議與回饋 15 參考文獻 16 表目錄 表 1 愛滋病毒感染者及其配對族群之基礎特性 19 表 2 愛滋病毒感染死亡者與愛滋病毒陰性死亡者之個案基礎特性 20 表 3 死亡個案生命最後一年臨終關懷服務利用相關因素之單變量與多變量分析 22 表 4 死亡個案生命最後一年其愛滋病毒感染與臨終關懷服務利用的關聯之分層分析 25 表 5 死亡個案生命最後三個月內使用維生醫療相關因素之單變量和多變量分析 26 表 6 使用臨終關懷服務與心肺復甦、氣管插管、機械式呼吸輔助和去顫之多變量分析 30 附錄 1 31 附錄 2 32 | |
dc.language.iso | zh-TW | |
dc.title | HIV感染與臨終治療期間安寧照護服務利用率之關聯 | zh_TW |
dc.title | Association Between HIV Infection and Utilization of Hospice Care Services during End-of-Life Treatment | en |
dc.type | Thesis | |
dc.date.schoolyear | 110-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 顏永豐(Yung-Feng Yen),詹珮君(Pei-Chun Chan) | |
dc.subject.keyword | 愛滋病毒,安寧照護,維生醫療,臨終,世代研究, | zh_TW |
dc.subject.keyword | HIV,hospice care,life-sustaining treatment,end-of-life,cohort study, | en |
dc.relation.page | 32 | |
dc.identifier.doi | 10.6342/NTU202203435 | |
dc.rights.note | 同意授權(限校園內公開) | |
dc.date.accepted | 2022-09-15 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 公共衛生碩士學位學程 | zh_TW |
dc.date.embargo-lift | 2022-10-04 | - |
顯示於系所單位: | 公共衛生碩士學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-1509202213541000.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 832.18 kB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。